Detection Of Ovarian Cancer Using Bio-Impedance
DOI:
https://doi.org/10.32628/IJSRSET251236Keywords:
Bio-impedance, Ovarian Cancer Detection, Instrumentation Amplifier (INA333), ADC (ADS1115), Signal Generator (AD9833), Microcontroller-Based Diagnostic SystemAbstract
Ovarian cancer is a highly fatal gynecologic malignancy often diagnosed at advanced stages due to the absence of reliable early diagnostic techniques. This study introduces a non-invasive diagnostic approach based on bio-impedance analysis to detect ovarian cancer in its early stages. Bio-impedance quantifies the opposition of biological tissues to an externally applied alternating current, which varies with tissue composition, membrane capacitance, and intracellular resistance. Malignant tissues exhibit distinct impedance profiles compared to healthy counterparts due to altered cellular architecture and dielectric properties. A hardware system was developed using surface-mounted Ag/AgCl electrodes for multi-frequency impedance acquisition across the abdominal region. The captured impedance spectra were processed and evaluated using signal conditioning techniques and classified through supervised machine learning algorithms to differentiate pathological from normal states. Experimental validation on tissue-equivalent phantoms demonstrated consistent impedance deviations correlating with simulated malignancy. The proposed system offers potential as a point-of-care, low-cost diagnostic tool capable of early anomaly identification without the need for imaging or invasive procedures. Future work will focus on clinical trials, impedance mapping optimization, and real-time embedded system integration to enhance diagnostic precision and portability in remote and primary care environments.
Downloads
References
M. Khalid, A. Akram, and S. Jabeen, "Detection of Ovarian Cancer Using Electrical Bioimpedance and Machine Learning," IEEE Transactions on Instrumentation and Measurement, vol. 70, pp. 1–9, 2021. [DOI: 10.1109/TIM.2021.3052614]
A. L. Pullan and D. W. Holdstock, "Impedance Measurements in Ovarian Cancer Diagnosis: A Clinical Study," Journal of Medical Engineering & Technology, vol. 43, no. 4, pp. 225–232, 2020.
T. Yang et al., "Bioimpedance Spectroscopy for Cancer Detection," Sensors, vol. 19, no. 20, pp. 4526–4535, 2019. [DOI: 10.3390/s19204526]
D. Holder (Ed.), Electrical Impedance Tomography: Methods, History and Applications, CRC Press, 2005.
El- Gammal, M. A., Sayed, F. E., & Allam, N. K. Comprehensive analysis of electrochemical biosensors for early ovarian cancer detection. RSC Advances, 2024.
Al- Ogaidi , I., et al. Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots. ChemComm, 2014.
ACS Sensors. Electrochemical Sensor for the Detection and Accurate Early Diagnosis of Ovarian Cancer. ACS Sensors, 2025.
MDPI Biosensors. Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid Using a Label-Free Electrochemical Biosensor. 2025.
BMC Cancer. Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial, 2021.
MDPI Diagnostics. Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study, 2024.
MDPI Cancers. Detection of Ovarian Cancer through Exhaled Breath by Electronic Nose: A Prospective Study, 2020.
PubMed. Detection of ovarian cancer via ATR-FTIR spectroscopy: comparative analysis of blood and urine bio fluids, 2021.
BMC Bioinformatics. Ovarian cancer detection from metabolomic LC/MS data using support vector machines, 2009.
BMC Bioinformatics. Ovarian cancer detection from metabolomic LC/MS data using support vector machines, 2009.
Bioengineering. Flexible bio electronic systems for impedance-based cancer detection, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Scientific Research in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution 4.0 International License.